{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:30:15Z","timestamp":1788877815839,"version":"build-2803163510"},"reference-count":88,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Front-line pharmaceutical interventions for treating acute graft-versus-host disease (GVHD) are not uniformly effective and have toxic side effects. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells with potent in vitro and in vivo immunosuppressive functions. Clinical translation of in vitro\u2013generated MDSCs has been limited because of requirements for multiple, high infusion doses, the relatively low yield from peripheral blood\u2013sourced MDSCs (PB-MDSCs), and inconsistent product quality. To circumvent these obstacles, we developed a methodology to generate MDSCs using human induced pluripotent stem cell (iPSC)\u2013derived CD34+ cells. Compared with PB-MDSCs, iPSC-derived MDSCs (iMDSCs) shared similar morphology, phenotype, and suppressive function. We found that the CD14+ iMDSC subset possessed the highest suppressor function. In previous studies, we reported that MDSCs transferred into mice with GVHD lost suppressor function because of inflammasome activation and immature myeloid cell maturation. In striking contrast to human PB-MDSCs, we show herein that iMDSCs retained 95% of suppressor function in vitro despite exposure to lipopolysaccharide (LPS) plus adenosine triphosphate (ATP), which are stimuli that activate the inflammasome via danger-associated molecular patterns released during early posttransplant conditioning and GVHD-induced injury. In an in vivo xenogenic GVHD model with PB mononuclear cells, iMDSCs significantly increased recipient survival without loss of antileukemia effects. iMDSC RNA sequencing and gene knockdown studies revealed that the maintenance of the purine metabolizing enzyme, phosphoglycerate dehydrogenase, during LPS plus ATP treatment, was linked to iMDSC inflammasome resistance. Taken together, these findings provide a platform for translating in vitro\u2013generated, off-the-shelf iMDSCs into the clinic for suppressing a spectrum of adverse immune responses, including GVHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025028562","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T18:18:51Z","timestamp":1753294731000},"page":"2047-2062","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease"],"prefix":"10.1182","volume":"146","author":[{"given":"Lie","family":"Ma","sequence":"first","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3669-2702","authenticated-orcid":false,"given":"Brent","family":"Koehn","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6971-3170","authenticated-orcid":false,"given":"Michael","family":"Zaiken","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-270X","authenticated-orcid":false,"given":"Keli L.","family":"Hippen","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Smith","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Allred","sequence":"additional","affiliation":[{"name":"2Department of Medicine, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-5286","authenticated-orcid":false,"given":"Robin","family":"Williams","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-6445","authenticated-orcid":false,"given":"Ke","family":"Yao","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0841-7198","authenticated-orcid":false,"given":"Jordan","family":"Fink","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-2695","authenticated-orcid":false,"given":"Asim","family":"Saha","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Koop","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Payne","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Widelak","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Panoskaltsis-Mortari","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Riddle","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0957-4380","authenticated-orcid":false,"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7314-2550","authenticated-orcid":false,"given":"Cindy","family":"Eide","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Xia","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec D.","family":"Witty","sequence":"additional","affiliation":[{"name":"3Fate Therapeutics, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Mehta","sequence":"additional","affiliation":[{"name":"3Fate Therapeutics, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Denholtz","sequence":"additional","affiliation":[{"name":"3Fate Therapeutics, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hefazi","sequence":"additional","affiliation":[{"name":"4T Cell Engineering Laboratory and the Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Hani","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad S.","family":"Kenderian","sequence":"additional","affiliation":[{"name":"4T Cell Engineering Laboratory and the Division of Hematology, Mayo Clinic, Rochester, MN"},{"name":"5Department of Molecular Medicine, Mayo Clinic, Rochester, MN"},{"name":"6Department Immunology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-1715","authenticated-orcid":false,"given":"Jeffrey J.","family":"Molldrem","sequence":"additional","affiliation":[{"name":"7ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Kean","sequence":"additional","affiliation":[{"name":"8Division of Pediatric Hematology and Oncology, Boston Children\u2019s Hospital, Boston, MA"},{"name":"9Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-3585","authenticated-orcid":false,"given":"Bahram","family":"Valamehr","sequence":"additional","affiliation":[{"name":"3Fate Therapeutics, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-9841","authenticated-orcid":false,"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"12","key":"2025102311221252100_bib2","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: challenges and progress","volume":"105","author":"Granot","year":"2020","journal-title":"Haematologica"},{"key":"2025102311221252100_bib3","unstructured":"Bolon\n              YT\n            , AtshanR, Allbee-JohnsonM, Estrada-MerlyN, LeeSJ. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides. 2022. Accessed 2024. http:\/\/www.cibmtr.org\/."},{"key":"2025102311221252100_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"2025102311221252100_bib5","volume-title":"Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation: Models in Discovery and Translation","author":"Soci\u00e9","year":"2012","edition":"1st ed"},{"issue":"3","key":"2025102311221252100_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2014-01-514786","article-title":"Acute graft-versus-host disease: a bench-to-bedside update","volume":"124","author":"Holtan","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2025102311221252100_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard","year":"2020","journal-title":"Leukemia"},{"issue":"22","key":"2025102311221252100_bib8","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"2025102311221252100_bib9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2023020073","article-title":"Novel developments in the prophylaxis and treatment of acute GVHD","volume":"142","author":"Jamy","year":"2023","journal-title":"Blood"},{"issue":"4","key":"2025102311221252100_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.2019000953","article-title":"Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease","volume":"136","author":"Toubai","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2025102311221252100_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2019000951","article-title":"Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance","volume":"136","author":"Voermans","year":"2020","journal-title":"Blood"},{"issue":"10","key":"2025102311221252100_bib12","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3390\/jcm10102050","article-title":"The role of myeloid-derived suppressor cells (MDSCs) in graft-versus-host disease (GVHD)","volume":"10","author":"Demosthenous","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"2025102311221252100_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbmt.2013.01.008","article-title":"Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice","volume":"19","author":"Wang","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"2025102311221252100_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2025102311221252100_bib15","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"2025102311221252100_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coi.2018.03.009","article-title":"Plasticity of myeloid-derived suppressor cells in cancer","volume":"51","author":"Tcyganov","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2025102311221252100_bib17","doi-asserted-by":"crossref","first-page":"14249","DOI":"10.1038\/s41598-020-71289-z","article-title":"Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo","volume":"10","author":"Cai","year":"2020","journal-title":"Sci Rep"},{"key":"2025102311221252100_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fimmu.2019.00183","article-title":"GM-CSF promotes the expansion and differentiation of cord blood myeloid-derived suppressor cells, which attenuate xenogeneic graft-vs.-host disease","volume":"10","author":"Park","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"2025102311221252100_bib19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J Immunol"},{"issue":"19","key":"2025102311221252100_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2019001950","article-title":"Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD","volume":"134","author":"Koehn","year":"2019","journal-title":"Blood"},{"issue":"13","key":"2025102311221252100_bib20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2015-03-634691","article-title":"GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells","volume":"126","author":"Koehn","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2025102311221252100_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/sctm.20-0247","article-title":"Hematopoietic stem cells from pluripotent stem cells: clinical potential, challenges, and future perspectives","volume":"9","author":"Demirci","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"2025102311221252100_bib22","doi-asserted-by":"crossref","first-page":"sxaf011","DOI":"10.1093\/stmcls\/sxaf011","article-title":"Immunoregulatory iPSC-derived non-lymphoid progeny in autoimmunity and GVHD alloimmunity","volume":"43","author":"Ma","year":"2025;  22","journal-title":"Stem Cells"},{"issue":"568","key":"2025102311221252100_bib23","doi-asserted-by":"crossref","first-page":"eaaz5618","DOI":"10.1126\/scitranslmed.aaz5618","article-title":"iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy","volume":"12","author":"Cichocki","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"2025102311221252100_bib24","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41467-018-07570-7","article-title":"Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections","volume":"9","author":"Ackermann","year":"2018","journal-title":"Nat Commun"},{"key":"2025102311221252100_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/srep00213","article-title":"A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs","volume":"2","author":"Valamehr","year":"2012","journal-title":"Sci Rep"},{"issue":"3","key":"2025102311221252100_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stemcr.2014.01.014","article-title":"Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells","volume":"2","author":"Valamehr","year":"2014","journal-title":"Stem Cell Rep"},{"issue":"3","key":"2025102311221252100_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nprot.2010.184","article-title":"Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells","volume":"6","author":"Choi","year":"2011","journal-title":"Nat Protoc"},{"issue":"3","key":"2025102311221252100_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2010-05-287607","article-title":"Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)","volume":"117","author":"Tolar","year":"2011","journal-title":"Blood"},{"key":"2025102311221252100_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ncomms1165","article-title":"An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells","volume":"2","author":"Tsutsui","year":"2011","journal-title":"Nat Commun"},{"issue":"7","key":"2025102311221252100_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2013.00062","article-title":"NanoLuc reporter for dual luciferase imaging in living animals","volume":"12","author":"Stacer","year":"2013","journal-title":"Mol Imaging"},{"issue":"1","key":"2025102311221252100_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2017.03.023","article-title":"Single-cell analysis identifies distinct stages of human endothelial-to-hematopoietic transition","volume":"19","author":"Guibentif","year":"2017","journal-title":"Cell Rep"},{"key":"2025102311221252100_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2018.01.009","article-title":"CD45 in human physiology and clinical medicine","volume":"196","author":"Rheinl\u00e4nder","year":"2018","journal-title":"Immunol Lett"},{"key":"2025102311221252100_bib40","first-page":"25","volume-title":"Atlas of Hematopathology: Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches","author":"Faramarz","year":"2013"},{"issue":"1","key":"2025102311221252100_bib41","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1038\/s41598-017-08121-8","article-title":"Classification of M1\/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis","volume":"7","author":"Bertani","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"2025102311221252100_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"2025102311221252100_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2014.00387","article-title":"The role of myeloid-derived suppressor cells in immune ontogeny","volume":"5","author":"Gantt","year":"2014","journal-title":"Front Immunol"},{"issue":"12","key":"2025102311221252100_bib44","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am J Transpl"},{"issue":"1-2","key":"2025102311221252100_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jim.2012.04.004","article-title":"Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples","volume":"381","author":"Kotsakis","year":"2012","journal-title":"J Immunol Methods"},{"issue":"6","key":"2025102311221252100_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional regulation of myeloid-derived suppressor cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"8","key":"2025102311221252100_bib47","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"2025102311221252100_bib48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2025102311221252100_bib49","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.4049\/jimmunol.170.11.5538","article-title":"Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression","volume":"170","author":"Schroeder","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"2025102311221252100_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1074-7613(01)00101-7","article-title":"STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation","volume":"14","author":"McLemore","year":"2001","journal-title":"Immunity"},{"issue":"6","key":"2025102311221252100_bib51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.cell.2019.08.009","article-title":"Fate mapping via Ms4a3-expression history traces monocyte-derived cells","volume":"178","author":"Liu","year":"2019","journal-title":"Cell"},{"issue":"3","key":"2025102311221252100_bib52","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.bbrc.2017.12.117","article-title":"Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis","volume":"495","author":"Ishibashi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2025102311221252100_bib53","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2012-06-437863","article-title":"Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation","volume":"121","author":"Kurotaki","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2025102311221252100_bib54","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1172\/JCI68189","article-title":"Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis","volume":"123","author":"Waight","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"2025102311221252100_bib55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"issue":"9","key":"2025102311221252100_bib56","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2014-09-600833","article-title":"IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production","volume":"125","author":"Y\u00e1\u00f1ez","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2025102311221252100_bib57","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"2025102311221252100_bib58","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/database\/bax094","article-title":"HisgAtlas 1.0: a human immunosuppression gene database","volume":"2017","author":"Liu","year":"2017","journal-title":"Database (Oxford)"},{"issue":"12","key":"2025102311221252100_bib59","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion","volume":"180","author":"Dugast","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"2025102311221252100_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"issue":"5","key":"2025102311221252100_bib61","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1172\/JCI74589","article-title":"Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell-mediated immunity","volume":"124","author":"Flies","year":"2014","journal-title":"J Clin Invest"},{"issue":"6475","key":"2025102311221252100_bib62","doi-asserted-by":"crossref","first-page":"eaay0524","DOI":"10.1126\/science.aay0524","article-title":"VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance","volume":"367","author":"ElTanbouly","year":"2020","journal-title":"Science"},{"issue":"3","key":"2025102311221252100_bib63","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/blood-2011-10-387977","article-title":"Contrasting acute graft-versus-host disease effects of Tim-3\/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells","volume":"120","author":"Veenstra","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2025102311221252100_bib64","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2013-12-545335","article-title":"Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice","volume":"123","author":"Toubai","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2025102311221252100_bib65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.2023020250","article-title":"A phase 2 trial of CD24Fc for prevention of graft-versus-host disease","volume":"143","author":"Magenau","year":"2024","journal-title":"Blood"},{"key":"2025102311221252100_bib31","first-page":"1","volume-title":"Proceedings of the Practice and Experience in Advanced Research Computing on Rise of the Machines (Learning)","author":"Baller","year":"2019"},{"key":"2025102311221252100_bib32","unstructured":"Andrews\n              S\n            \n          . FASTQC. A quality control tool for high throughput sequence data. 2010. Accessed 2023. https:\/\/github.com\/s-andrews\/FastQC."},{"issue":"15","key":"2025102311221252100_bib33","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"8","key":"2025102311221252100_bib34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2025102311221252100_bib35","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"issue":"7","key":"2025102311221252100_bib36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"2025102311221252100_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"2025102311221252100_bib66","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1038\/s41467-018-07868-6","article-title":"Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism","volume":"9","author":"Reid","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"2025102311221252100_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab"},{"issue":"4","key":"2025102311221252100_bib68","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cmet.2019.01.014","article-title":"Serine metabolism supports macrophage IL-1\u03b2 production","volume":"29","author":"Rodriguez","year":"2019","journal-title":"Cell Metab"},{"issue":"4","key":"2025102311221252100_bib69","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.molcel.2024.01.002","article-title":"Serine synthesis sustains macrophage IL-1\u03b2 production via NAD+-dependent protein acetylation","volume":"84","author":"Wang","year":"2024","journal-title":"Mol Cell"},{"issue":"5","key":"2025102311221252100_bib70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41423-024-01134-0","article-title":"Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through \u03b1-ketoglutarate and mTORC1 signaling","volume":"21","author":"Cai","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"2025102311221252100_bib71","doi-asserted-by":"crossref","first-page":"631353","DOI":"10.3389\/fimmu.2021.631353","article-title":"Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD","volume":"12","author":"Mendt","year":"2021","journal-title":"Front Immunol"},{"issue":"25","key":"2025102311221252100_bib72","doi-asserted-by":"crossref","first-page":"E2279","DOI":"10.1073\/pnas.1305987110","article-title":"piggyBac transposase tools for genome engineering","volume":"110","author":"Li","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2025102311221252100_bib73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41551-024-01195-6","article-title":"Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression","volume":"8","author":"Sirpilla","year":"2024","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"2025102311221252100_bib74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4049\/jimmunol.2000054","article-title":"Early T cell activation metrics predict graft-versus-host disease in a humanized mouse model of hematopoietic stem cell transplantation","volume":"205","author":"Hess","year":"2020","journal-title":"J Immunol"},{"issue":"9","key":"2025102311221252100_bib76","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1177\/0963689718780194","article-title":"An in vitro and in vivo study of the effect of dexamethasone on immunoinhibitory function of induced pluripotent stem cell-derived mesenchymal stem cells","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Transpl"},{"issue":"12","key":"2025102311221252100_bib77","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1182\/bloodadvances.2017012369","article-title":"161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS","volume":"2","author":"Sarhan","year":"2018","journal-title":"Blood Adv"},{"issue":"19","key":"2025102311221252100_bib78","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2013-10-533398","article-title":"CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets","volume":"123","author":"Gleason","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2025102311221252100_bib79","doi-asserted-by":"crossref","first-page":"2127455","DOI":"10.1080\/19490976.2022.2127455","article-title":"Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis","volume":"14","author":"Radojevi\u0107","year":"2022","journal-title":"Gut Microbes"},{"issue":"6","key":"2025102311221252100_bib80","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/2211-5463.12429","article-title":"Enhanced vulnerability to oxidative stress and induction of inflammatory gene expression in 3-phosphoglycerate dehydrogenase-deficient fibroblasts","volume":"8","author":"Hamano","year":"2018","journal-title":"FEBS Open Bio"},{"issue":"2","key":"2025102311221252100_bib81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"key":"2025102311221252100_bib82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fonc.2020.00109","article-title":"The generation and identity of human myeloid-derived suppressor cells","volume":"10","author":"Bergenfelz","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"2025102311221252100_bib83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"issue":"13","key":"2025102311221252100_bib84","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1242\/dev.134866","article-title":"Human haematopoietic stem cell development: from the embryo to the dish","volume":"144","author":"Ivanovs","year":"2017","journal-title":"Development"},{"issue":"2","key":"2025102311221252100_bib85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1189\/jlb.5MR1116-464R","article-title":"Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation","volume":"102","author":"Koehn","year":"2017","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2025102311221252100_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12967-018-1395-9","article-title":"Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy","volume":"16","author":"Zhang","year":"2018","journal-title":"J Transl Med"},{"key":"2025102311221252100_bib87","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fimmu.2019.00374","article-title":"Tolerogenic role of myeloid suppressor cells in organ transplantation","volume":"10","author":"Ochando","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"2025102311221252100_bib75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.1402861","article-title":"Donor requirements for regulatory T cell suppression of murine graft-versus-host disease","volume":"195","author":"Pierini","year":"2015","journal-title":"J Immunol"},{"issue":"8","key":"2025102311221252100_bib88","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajt.2023.01.030","article-title":"Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity","volume":"23","author":"Larson","year":"2023","journal-title":"Am J Transpl"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/17\/2047\/2417586\/blood_bld-2025-028562-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/17\/2047\/2417586\/blood_bld-2025-028562-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:22:29Z","timestamp":1761232949000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/17\/2047\/546315\/Inflammasome-resistant-IPSC-derived-myeloid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":88,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028562","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,23]]},"published":{"date-parts":[[2025,10,23]]}}}